Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.
- DOI
- 10.1080/13696998.2026.2726640
- Published
- 2026 Dec
- Container
- Journal of medical economics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13696998.2026.2726640,
title = {Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.},
author = {Simuzingili M and Yi Z and Favre-Bulle A and Mutschler T and Tsoumani E and Owusu-Edusei K},
year = {2026},
journal = {Journal of medical economics},
doi = {10.1080/13696998.2026.2726640},
url = {https://doi.org/10.1080/13696998.2026.2726640}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21. AU - Simuzingili M AU - Yi Z AU - Favre-Bulle A AU - Mutschler T AU - Tsoumani E AU - Owusu-Edusei K PY - 2026 JO - Journal of medical economics DO - 10.1080/13696998.2026.2726640 UR - https://doi.org/10.1080/13696998.2026.2726640 ER -
APA
M, S., Z, Y., A, F., T, M., E, T., & K, O. (2026). Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18-64 years in Switzerland using PCV21.. Journal of medical economics. https://doi.org/10.1080/13696998.2026.2726640
Source records
- pubmed · retrieved 2026-09-26T18:23:47.655Z